61 related articles for article (PubMed ID: 10964660)
1. Regulation of ferritin mRNA translation in primary erythroblasts: exogenous c-Kit plus EpoR signaling mimics v-ErbA oncoprotein activity.
Mikulits W; Schranzhofer M; Deiner EM; Beug H; Müllner EW
Biochem Biophys Res Commun; 2000 Aug; 275(2):292-4. PubMed ID: 10964660
[TBL] [Abstract][Full Text] [Related]
2. Impaired ferritin mRNA translation in primary erythroid progenitors: shift to iron-dependent regulation by the v-ErbA oncoprotein.
Mikulits W; Schranzhofer M; Bauer A; Dolznig H; Lobmayr L; Infante AA; Beug H; Müllner EW
Blood; 1999 Dec; 94(12):4321-32. PubMed ID: 10590077
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
4. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
5. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
[TBL] [Abstract][Full Text] [Related]
6. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptor hyperexpression in primary erythroblasts is lost on transformation by avian erythroblastosis virus.
Lobmayr L; Sauer T; Killisch I; Schranzhofer M; Wilson RB; Ponka P; Beug H; Müllner EW
Blood; 2002 Jul; 100(1):289-98. PubMed ID: 12070039
[TBL] [Abstract][Full Text] [Related]
8. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
9. Sarcoma and thyroid disorders: a common etiology?
Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
[TBL] [Abstract][Full Text] [Related]
10. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
11. V-erbA generates ribosomes devoid of RPL11 and regulates translational activity in avian erythroid progenitors.
Nguyen-Lefebvre AT; Leprun G; Morin V; Viñuelas J; Couté Y; Madjar JJ; Gandrillon O; Gonin-Giraud S
Oncogene; 2014 Mar; 33(12):1581-9. PubMed ID: 23563180
[TBL] [Abstract][Full Text] [Related]
12. Association of v-ErbA with Smad4 disrupts TGF-beta signaling.
Erickson RA; Liu X
Mol Biol Cell; 2009 Mar; 20(5):1509-19. PubMed ID: 19144825
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
14. The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation.
Mey A; Gandrillon O; McNagny KM; Clegg DO; Samarut J
Oncogene; 2002 Apr; 21(18):2864-72. PubMed ID: 11973646
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and erythropoietin receptor expression in human cancer.
Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
[TBL] [Abstract][Full Text] [Related]
16. KIT associated intracellular tyrosines play an essential role in EpoR co-signaling.
Hong L; Ramdas B; Chen J; Harris C; Wojchowski DM; Kapur R
Cell Signal; 2008 Aug; 20(8):1513-20. PubMed ID: 18538998
[TBL] [Abstract][Full Text] [Related]
17. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
19. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
20. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
